Heather D. Turner

Insider Reports History

Location
San Diego, CA
Signature
/s/ Marc Panoff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heather D. Turner:

Company Role Class Num Shares Value Price $ Report Date Ownership
LB PHARMACEUTICALS INC Chief Executive Officer, Director Employee Stock Option (Right to Buy) 971,828 10 Sep 2025 Direct
Lyell Immunopharma, Inc. Chief General Counsel Option (right to buy) 300,000 16 Mar 2022 Direct
Terns Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 45,000 11 Jun 2025 Direct

Insider Reports Filed by Heather D. Turner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LBRX LB PHARMACEUTICALS INC 10 Sep 2025 5 $0 4 Chief Executive Officer, Director 12 Sep 2025, 18:25
LBRX LB PHARMACEUTICALS INC 10 Sep 2025 0 $0 3 Chief Executive Officer, Director 10 Sep 2025, 19:31
TERN Terns Pharmaceuticals, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 17:43
TERN Terns Pharmaceuticals, Inc. 18 Nov 2024 1 $0 4 Director 19 Nov 2024, 18:30
TERN Terns Pharmaceuticals, Inc. 18 Nov 2024 0 $0 3 Director 19 Nov 2024, 18:22
LYEL Lyell Immunopharma, Inc. 16 Mar 2022 1 $0 4 Chief General Counsel 18 Mar 2022, 16:11
LYEL Lyell Immunopharma, Inc. 16 Jun 2021 0 $0 3 Chief General Counsel 16 Jun 2021, 19:24